Abstract:STRESZCZENIE Cel pracy. Zbadanie i ocena skuteczności klinicznej i bezpieczenstwa przeskornego plastra z klonidyną w leczeniu zespolu Tourette’a (TS). Material i metody. Grupa 130 dzieci w wieku od 2 do 15 lat z zespolem Tourette’a zostala zrandomizowana do dwoch grup: 71 dzieci z badanej grupy bylo leczonych plastrem przezskornym z klonidyną, zaś 59 z grupy kontrolnej – haloperidolem. Po czterech tygodniach leczenia skutecznośc kliniczna zostala oceniona za pomocą skali Yale Globar Tic Severity Scale (YGTSS). Skutecznośc krotkoterminowa, objawy uboczne leczenia zostaly ocenione pod koniec leczenia, zaś skutecznośc dlugoterminową, jak rowniez czestośc nawrotow oceniono po pol roku od zakonczenia leczenia. Wyniki. Punktacja YGTSS w obu grupach obnizyla sie po czterech tygodniach leczenia, ale grupa chorych leczonych klonidyną wykazala wiekszą redukcje tikow w ogolnej punktacji tikowej (61,7 ± 7,3%), niz grupa leczonych haloperidolem (40,8 ±6,5%; P<0,05). Średni wspolczynnik skuteczności przezskornego plastra z klonidyną wynosil 81,7% (skutecznośc u 58 chorych), podczas gdy w przypadku doustnego haloperidolu skutecznośc wynosila 66,1% (skutecznośc u 39 chorych) (p<0,05). Nie obserwowano powaznych objawow ubocznych w zadnej z badanych grup. Niewielkie objawy uboczne pod postacią spadku ciśnienia krwi i zawrotow glowy obserwowano u jednego pacjenta leczonego przezskornie klonidyną. W grupie leczonych haloperidolem obserwowano lagodną miotonie, nudności lub sennośc u sześciu chorych. Slowa kluczowe: zespol Tourett’a, dzieci, leczenie, przezskorne plastry klonidyny ABSTRACT Objective. To examine and evaluate the clinical efficacy and safety of clonidine transdermal patch in treating Tourette syndrome. (TS). Material and Methods. A total of 130 children aged from 2 to 15 years with TS were randomized into two groups: 71 patients in the treated group were treated with clonidine transdermal patch and 59 in the control group were treated with haloperidol. After 4 weeks of treatment, the clinical efficacy was assessed by the Yale Global Tic Severity Scale(YGTSS). The short-term efficacy and adverse reaction of treatment were assessed at the end of treatment, the longterm efficacy as well as the recurrent rate were evaluated half a year after the end of treatment. Results. The YGTSS score in both groups decreased after 4 weeks of treatment, but the clonidine transdermal patch group showed a higher reduction in the overall tic symptom scores (61.7 ± 7.3%) than that in the haloperidol group. (40.8 ±6.5%; P<0.05). The overall effective rate in Clonidine transdermal patch treatment was 81.7% (effective in 58 patients) and 66.1% to oral haloperidol (effective in 39 patients) (p<0.05). There were no severe adverse events in both groups, but mild side effects (decreased blood pressure and dizziness) were observed in 1 patient in the clonidine transdermal patch group. Mild hypermyotonia, drowsiness or lassitude as side effects occurred in 6 patients in the haloperidol group. Conclusion. Clonidine transdermal patch treatment in TS Chinese children was more effective with lower incidence of adverse reactions and lower recurrent rate as compared with haloperidol group. Clonidine represents a new therapeutic option for the treatment of tic disorder.

Randomized Double-Blind Multicentre Placebo-Controlled Clinical Trial of the Clonidine Adhesive Patch for the Treatment of Tic Disorders.

Randomized,double-blind,multi-centers,clonidine adhesive patch placebo-controlled parallel-designed clinical trial in treating tic disorder

Efficacy of Clonidine Adhesive Patch for Patients With Tourette Syndrome: A Randomized, Double-blind, Placebo-Controlled, Multicenter Clinical Trial

Clonidine Patch for Tourette Syndrome With Attention-Deficit/Hyperactivity Disorder

Clinical Assessment of Treatment of Tourette Syndrome in Chinesechildren with Clonidine Transdermal Patch

In Vitro and in Vivo Characterization of A Newly Developed Clonidine Transdermal Patch for Treatment of Attention Deficit Hyperactivity Disorder in Children

Safety and efficacy of clonidine hydrochloride extended –release (CLON-XR) for treatment of attention deficit hyperactivity disorder in Chinese children and adolescents: a multi-center, placebo-controlled, randomized, double-blind study

The Clinical Intervention Choice For Pediatric Tic Disorder Patients From A Tertiary Children'S Hospital In China: A Large-Scale Retrospective Study Based On Electronic Medical Records

Clinical efficacy and safety of acupuncture treatment of TIC disorder in children: A systematic review and meta-analysis of 22 randomized controlled trials

Clinical study on psychological interventions for pediatric patients with Tic disorder and their parents

Transdermal clonidine in mild hypertension. A randomized, double-blind, placebo-controlled trial

The Efficacy of Acupuncture on Tic Disorders in Children: A Retrospective and Propensity Score-Matched Study

Trends and quality assessment of randomized controlled trials of western medicine for tic disorders in China

Acupuncture and other traditional Chinese medicine therapies in the treatment of children's tic syndrome: A network meta-analysis

Cognitive behavioural therapy in groups for medicated adults with attention deficit hyperactivity disorder: protocol for a randomised controlled trial

One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension--a multicentre open label study. The Antihypertensive Patch Italian Study (APIS) Investigators

Randomized, double-blind, placebo-controlled trial of aripiprazole oral solution in children and adolescents with Tourette's disorder

Efficacy and safety of transcranial pulse stimulation in young adolescents with attention-deficit/hyperactivity disorder: a pilot, randomized, double-blind, sham-controlled trial

Clinical Study on the Effect of Qufeng Zhidong Decoction on 31 Cases of Children Tic Disorder

Retrospective Study on the Therapeutic Effect of Repetitive Transcranial Magnetic Stimulation Combined with Tiapride Hydrochloride Tablets in Children with Attention Deficit Hyperactivity Disorder

Clinical management of children with tic disorder: insights from therapeutic visits in China—a real-world study